Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 78920806 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Andrew M. Abrams |
Attorney Docket Number | Gennium-0020 |
Law Office Assigned | L10 |
Employee Name | HERMAN, RUSS |
2006-06-30 | Application Filed |
2008-05-12 | Abandon |
2008-06-07 | Location: TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED |
2008-06-07 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Owner: | ![]() |
Address | Suite 200 2180 Meadowvale Boulevard Mississauga CA L5N 5S3 |
Legal Entity Type | Corporation |
Legal Entity State | CA |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Prescription and over-the-counter pharmaceutical preparations, namely: analgesics; anesthetics; anti-allergic preparations; anti-anemia drugs; anti-asthma preparations; antibiotic; anti-convulsants; antidepressants; anti-diabetic preparations; anti-diarrheal preparations; antifungal preparations; antihistamines; anti-hypertensive drugs; anti-infective agents; antiinflammatories; anti-neoplastics; antipyretics; antispasmodics; anti-viral agents; autonomic agents; bronchodilators; cardiovascular drugs; central nervous system depressants; central nervous system stimulants; cholesterol-lowering agents; diuretics; preparations for the treatment of ear, nose and throat disorders; preparations for the treatment of electrolytic, caloric and water balance disorders; gastrointestinal drugs; hematological drugs; hormonal agents; immunosuppressive agents; laxatives; lipid-metabolism regulating agents; mineral preparations for medical use; muscle relaxants; anti-inflammatory NSAID preparations; opioid narcotics; ophthalmic preparations; psychotherapeutic agents; psychotropic agents; sedatives; vitamin preparations for medical use; immune modulators; anti-acne agents; anti-wart drugs; anxiolytic drugs for treating anxiety; drugs for treating colds and flu, namely, decongestants, mucolytic preparations and cough suppressants; anti-contraceptive drugs; dermatological preparations for the treatment of scalp and skin disorders, namely, dandruff, eczema, aging spots and other skin conditions; anti-lipidemic drugs; thyroid medications; vaccines; drugs for the treatment of menopause; anti-obesity drugs; anti-arthritic drugs; drugs for treatment of urinary tract infections; anthelminthic drugs; dietary supplements; nutraceuticals for use as dietary supplements |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2006-07-07 | 1 NWAP I:Incoming Correspondence |
NOTICE OF PSEUDO MARK MAILED | 2006-07-08 | 2 MPMK O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2006-12-04 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2006-12-06 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2006-12-06 | 5 GNRT F:First Action |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2007-05-03 | 6 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2007-05-03 | 7 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2007-05-04 | 8 TEME I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2007-05-07 | 9 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2007-05-07 | 10 GNSL S: |
ASSIGNED TO LIE | 2007-11-08 | 11 ALIE A:Allowance for Publication |
LIE CHECKED SUSP - TO ATTY FOR ACTION | 2007-11-08 | 12 RCCK S: |
SUSPENSION INQUIRY WRITTEN | 2007-11-09 | 13 CNSI R:Renewal |
INQUIRY TO SUSPENSION E-MAILED | 2007-11-09 | 14 GNSI S: |
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2007-11-09 | 15 GNS2 O:Outgoing Correspondence |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2008-06-07 | 16 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2008-06-09 | 17 MAB2 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.